Discovery and biological evaluation of phthalazines as novel non-kinase TGFβ pathway inhibitors Journal Article


Authors: Kharbanda, A.; Zhang, L.; Saha, D.; Tran, P.; Xu, K.; Li, M. O.; Leung, Y. K.; Frett, B.; Li, H. Y.
Article Title: Discovery and biological evaluation of phthalazines as novel non-kinase TGFβ pathway inhibitors
Abstract: TGFβ is crucial for the homeostasis of epithelial and neural tissues, wound repair, and regulating immune responses. Its dysregulation is associated with a vast number of diseases, of which modifying the tumor microenvironment is one of vital clinical interest. Despite various attempts, there is still no FDA-approved therapy to inhibit the TGFβ pathway. Major mainstream approaches involve impairment of the TGFβ pathway via inhibition of the TGFβRI kinase. With the purpose to identify non-receptor kinase-based inhibitors to impair TGFβ signaling, an in-house chemical library was enriched, through a computational study, to eliminate TGFβRI kinase activity. Selected compounds were screened against a cell line engineered with a firefly luciferase gene under TGFβ-Smad-dependent transcriptional control. Results indicated moderate potency for a molecule with phthalazine core against TGFβ-Smad signaling. A series of phthalazine compounds were synthesized and evaluated for potency. The most promising compound (10p) exhibited an IC50 of 0.11 ± 0.02 μM and was confirmed to be non-cytotoxic up to 12 μM, with a selectivity index of approximately 112-fold. Simultaneously, 10p was confirmed to reduce the Smad phosphorylation using Western blot without exhibiting inhibition on the TGFβRI enzyme. This study identified a novel small-molecule scaffold that targets the TGFβ pathway via a non-receptor-kinase mechanism. © 2021
Keywords: cytokines; non-kinase inhibitor; pthalazine derivatives; tgf-β inhibitor; tgf-β pathway inhibitor
Journal Title: European Journal of Medicinal Chemistry
Volume: 223
ISSN: 0223-5234
Publisher: Elsevier Inc.  
Date Published: 2021-11-05
Start Page: 113660
Language: English
DOI: 10.1016/j.ejmech.2021.113660
PROVIDER: scopus
PUBMED: 34246853
PMCID: PMC9472513
DOI/URL:
Notes: Article -- Export Date: 2 August 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ming Li
    110 Li
  2. Ke   Xu
    11 Xu